As policymakers continue to discuss healthcare legislation, the AHA has developed several new resources to help hospitals and other stakeholders understand the proposals and their potential impact. These include a summary of current congressional price transparency activity and AHA recommendations, as well as a detailed side-by-side comparison of House and Senate price transparency bills.

The AHA also has released a comprehensive side-by-side comparison of three 340B reform proposals under consideration in Congress, including the 340B for Patients Act, the SECURE 340B Act and the SUSTAIN 340B Act. The resource outlines how each proposal would address critical issues such as patient definition, contract pharmacies, transparency requirements, rebate models and program oversight.

Headline
The AHA and its co-plaintiffs Nov. 16 filed a reply brief urging a federal court to block implementation of the Health Resources and Services Administration’s…
Headline
The AHA Oct. 27 submitted comments on the Supporting Underserved and Strengthening Transparency, Accountability, and Integrity Now and for the Future of 340B…
Headline
The U.S. District Court for the District of Maine should deny motions by several drug companies and Pharmaceutical Research and Manufacturers of America to…
Headline
The AHA today voiced support () for the 340B Rebate Model Delay Act (H.R. 10770)in a letter to the bill’s House sponsors. The bipartisan bill would pause the…
Headline
The AHA, the Maine Hospital Association and four safety-net hospitals Oct. 9 filed a lawsuit in the U.S. District Court for the District of Maine challenging…
Headline
The AHA, the New Hampshire Hospital Association and 340B Health have filed an amicus brief supporting Mary Hitchcock Memorial Hospital’s request for a…